类风湿关节炎与骨关节炎试验人群适用性:女性比例充足但老年人代表性不足的系统综述与Meta分析
该研究通过系统检索比较了2016–2017年发表的RA和OA随机对照试验(RCT)与2013–2017年的人群研究(PBS)中老年人和女性的代表性。共纳入265项RCT(51,240例)和53项PBS(523,630例),发现RA和OA的RCT中老年人比例及平均年龄均显著低于PBS,而女性比例相当。结论认为女性代表性充足,但老年人代表性不足可能限制当前证据对该增长亚组的适用性。
要点
- RA和OA的RCT中老年人比例显著低于人群研究,女性比例则相当。
- RCT平均年龄较PBS低:RA低5.2岁,OA低4.7岁(均p≤0.001)。
- 需改善老年人临床试验纳入并将年龄作为结局决定因素进行研究。
核心结论
- 女性在RA和OA试验中代表性充足,但老年人代表性不足,可能限制当前证据对该亚组的适用性。
- 亟需改善老年人临床试验纳入并将年龄作为结局决定因素进行研究。
研究设计与样本
- 系统综述与随机效应Meta分析。
- 四项MEDLINE系统检索纳入2016–2017年发表的RA和OA任何干预的RCT,以及2013–2017年发表的RA和OA人群研究(PBS)。
- 共纳入265项RCT(51,240例参与者)和53项PBS(523,630例参与者)。
- 按疾病(RA和OA)和研究类型(RCT和PBS)分层估计老年人(≥65岁)比例、平均年龄及其标准差(SD)和女性比例,随后比较分层估计值。
主要发现
- RA中RCT较PBS老年人比例低−0.18(95%CI −0.22至−0.13);OA中低−0.20(−0.30至−0.09)。
- RA中RCT较PBS平均年龄低−5.2岁(−6.8至−3.5);OA中低−4.7岁(−7.5至−2.0)。
- RA中RCT较PBS年龄SD低−1.9岁(−2.6至−1.3);OA中低−2.7岁(−4.2至−1.2)。
- 上述所有比较p≤0.001。
- RA和OA中RCT与PBS的女性比例相当。
关键数值与推荐
- 老年人定义为≥65岁。
- RA中RCT较PBS老年人比例差异−0.18(95%CI −0.22至−0.13),平均年龄差异−5.2岁(−6.8至−3.5),年龄SD差异−1.9岁(−2.6至−1.3),均p≤0.001。
- OA中RCT较PBS老年人比例差异−0.20(95%CI −0.30至−0.09),平均年龄差异−4.7岁(−7.5至−2.0),年龄SD差异−2.7岁(−4.2至−1.2),均p≤0.001。
临床怎么用
- 解读RA和OA的RCT证据时需注意老年人代表性不足,外推至≥65岁患者应谨慎。
- 临床决策中应关注年龄对结局的影响,不能仅依赖以较年轻人群为主的RCT证据。
- 推动未来试验改善老年人纳入并报告年龄分层结果。
局限性
- 仅纳入2016–2017年发表的RCT和2013–2017年发表的PBS,时间范围有限。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate whether elderly people and women are adequately represented in randomized controlled trials (RCT) in rheumatoid arthritis (RA) and osteoarthritis (OA). METHODS: Four systematic searches in MEDLINE yielded RCT in RA and OA on any intervention published in 2016 and 2017 and population-based studies (PBS) in RA and OA published between 2013 and 2017. Random effects meta-analyses estimated the pooled proportion of elderly people (defined as being ≥ 65 years old), the mean age, its standard deviation (SD), and the proportion of women stratified by disease (RA and OA) and study type (RCT and PBS). Stratified estimates were subsequently compared. RESULTS: 265 RCT comprising 51,240 participants and 53 PBS comprising 523,630 participants were included. In both RA and OA, RCT included lower proportions of elderly people than PBS: RA -0.18 (95% confidence interval -0.22 to -0.13); OA -0.20 (-0.30 to -0.09); had lower mean ages: RA -5.2 years (-6.8 to -3.5); OA -4.7 years (-7.5 to -2.0); and smaller SD: RA -1.9 years (-2.6 to -1.3); OA -2.7 years (-4.2 to -1.2); (all comparisons: p ≤ 0.001). Proportions of women were comparable in RCT compared to PBS in both RA and OA. CONCLUSIONS: While women are adequately represented in RA and OA trials, the elderly are underrepresented, probably limiting applicability of current evidence to this growing subgroup. It is urgent to improve the inclusion of elderly people in clinical trials and study age as a determinant for outcome.
引用
- Palmowski A, Buttgereit T, Palmowski Y, et al. Applicability of trials in rheumatoid arthritis and osteoarthritis: A systematic review and meta-analysis of trial populations showing adequate proportion of women, but underrepresentation of elderly people. Semin Arthritis Rheum. 2018. PMID: 30466715. doi:10.1016/j.semarthrit.2018.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。